BlackRock Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-9,178
Closed -$77K 4087
2016
Q1
$77K Buy
9,178
+152
+2% +$1.27K ﹤0.01% 3245
2015
Q4
$111K Buy
9,026
+36
+0.4% +$988 ﹤0.01% 3272
2015
Q3
$547K Sell
8,990
-198
-2% -$14.3K ﹤0.01% 2993
2015
Q2
$717K Buy
9,188
+3,726
+68% +$313K ﹤0.01% 2990
2015
Q1
$371K Buy
5,462
+46
+0.8% +$3.94K ﹤0.01% 3075
2014
Q4
$502K Buy
5,416
+41
+0.8% +$4.24K ﹤0.01% 3012
2014
Q3
$566K Buy
5,375
+605
+13% +$84.2K ﹤0.01% 2903
2014
Q2
$683K Buy
4,770
+767
+19% +$112K ﹤0.01% 2862
2014
Q1
$604K Buy
4,003
+136
+4% +$26.8K ﹤0.01% 2849
2013
Q4
$709K Buy
3,867
+563
+17% +$103K ﹤0.01% 2757
2013
Q3
$730K Buy
3,304
+197
+6% +$41.9K ﹤0.01% 2668
2013
Q2
$543K Buy
+3,107
New +$810K ﹤0.01% 2807

Other funds holding MDGL